Savencia SA

As of June 30, 2026, Savencia SA carries a market capitalization of 859.27M, placing it among publicly traded companies globally. Its enterprise value stands at 2.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Savencia SA's next confirmed earnings release is scheduled for March 11, 2027.

As of June 30, 2026, Savencia SA has 12.90M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Savencia SA maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Savencia SA's stock has declined approximately 8.14% over the past 52 weeks. The 50-day moving average sits at 59.54, while the 200-day moving average is 62.59.

As of June 30, 2026, Savencia SA holds 726.99M in cash and equivalents against 1.70B in total debt, resulting in a net debt position of 925.42M. Total book value stands at 1.89B, with working capital of 480.38M providing operational flexibility.

Savencia SA's most recent stock split took place on September 1, 2000 with a 1:8 split ratio.